Nwam LLC boosted its position in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 16.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,385 shares of the technology company’s stock after purchasing an additional 2,301 shares during the quarter. Nwam LLC’s holdings in Veeva Systems were worth $2,908,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in VEEV. Principal Financial Group Inc. grew its holdings in shares of Veeva Systems by 7.0% during the first quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company’s stock worth $727,513,000 after buying an additional 271,252 shares in the last quarter. State Street Corp lifted its stake in shares of Veeva Systems by 2.4% during the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company’s stock valued at $801,267,000 after buying an additional 85,695 shares during the period. Geode Capital Management LLC lifted its stake in shares of Veeva Systems by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 3,172,716 shares of the technology company’s stock valued at $706,442,000 after buying an additional 23,117 shares during the period. AQR Capital Management LLC boosted its position in Veeva Systems by 31.2% during the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock worth $706,078,000 after acquiring an additional 574,164 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Veeva Systems by 12.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,728,089 shares of the technology company’s stock worth $385,761,000 after acquiring an additional 189,093 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
Key Veeva Systems News
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva announced Veeva Falcon Safety, an agentic safety-operations product designed to automate adverse-event intake, case processing, and follow-up across all E2B-compliant safety systems and intake channels. The offering could reduce costs, accelerate workflows, and strengthen compliance for biopharmaceutical customers. Veeva Falcon Safety announcement
- Positive Sentiment: Recent results remain a support for the stock: Veeva reported quarterly revenue of approximately $928 million, up 17.6% year over year, and EPS of $2.35 versus the $2.23 consensus estimate. Management’s call highlighted accelerating Vault CRM adoption and sustained growth. Veeva Q2 2027 earnings call transcript
- Neutral Sentiment: Michael Burry trimmed his Veeva position after the stock nearly doubled, reportedly following a trade-management rule to take profits. The move may attract attention, but it appears to reflect portfolio management rather than a specific deterioration in Veeva’s business outlook. Michael Burry trims Veeva position
- Negative Sentiment: Insider Thomas Schwenger sold 10,000 shares for approximately $2.8 million, reducing his direct stake by about 34%. Because the sale was conducted under a pre-arranged Rule 10b5-1 plan, it is a relatively limited bearish signal, but it can still weigh on sentiment following Veeva’s sharp rally. Veeva insider sale
- Negative Sentiment: With Veeva trading near its 12-month high and at roughly 46 times earnings, investors may be locking in gains and demanding continued strong execution. Profit-taking by prominent investors and the insider sale provide near-term selling pressure despite the company’s favorable growth profile.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Veeva Systems
Insider Transactions at Veeva Systems
In other Veeva Systems news, insider Thomas D. Schwenger sold 10,000 shares of the company’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the sale, the insider directly owned 19,449 shares in the company, valued at $5,471,587.17. This represents a 33.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.
Veeva Systems Stock Down 2.2%
NYSE:VEEV opened at $279.34 on Wednesday. The company has a market cap of $45.38 billion, a P/E ratio of 45.94, a P/E/G ratio of 1.22 and a beta of 0.97. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50. The firm’s 50 day moving average is $213.52 and its two-hundred day moving average is $185.80.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. Veeva Systems’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter last year, the business earned $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Research analysts forecast that Veeva Systems Inc. will post 6.7 earnings per share for the current fiscal year.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
